NeuroOne Reports Q2 2026 Earnings with Improved Net Loss
NeuroOne (NMTC) reported a narrowed net loss of $2.1 million for the second quarter of fiscal year 2026, driven by increased product revenue from its OneRF line and cost control measures. The company regained NASDAQ compliance through a reverse stock split and is progressing toward international distribution with ISO certification.
Topics: financials net_loss operating_expenses product_sales revenue_growth